Home > Insider Trading > Filing (0001062993-25-001237)

Filing Details

Accession Number:: 0001062993-25-001237
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-01-29 16:35:39
Reporting Period:: 2025-01-27

Accepted Time:: 2025-01-29 16:35:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
842023	Bio-Techne Corp	TECH	Biological Products, (No Disgnostic Substances) (2836)	411427402

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1739054	Kim Kelderman	614 Mckinley Place Ne Minneapolis MN 55413	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-01-27	13,392	$37.70	52,396	No	4	M	Direct
Common Stock	Disposition	2025-01-27	11,731	$77.19	40,665	No	4	S	Direct
Common Stock	Disposition	2025-01-27	1,661	$77.95	39,004	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2025-01-27	13,392	$0.00	13,392	$37.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-05-01	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$44.33	2025-08-08	84,308	84,308	Direct
Common Stock	Stock Option (Right to Buy)	$47.60	2026-08-07	109,536	109,536	Direct
Common Stock	Stock Option (Right to Buy)	$66.97	2027-08-05	115,724	115,724	Direct
Common Stock	Stock Option (Right to Buy)	$120.46	2028-08-06	25,944	25,944	Direct
Common Stock	Performance Restricted Stock Units	$0.00		6,984	6,984	Direct
Common Stock	Performance Stock Options (Right to Buy)	$94.52	2029-08-15	21,704	21,704	Direct
Common Stock	Stock Options (Right to Buy)	$94.52	2029-08-15	28,940	28,940	Direct
Common Stock	Performance Restricted Stock Units	$0.00		8,873	8,873	Direct
Common Stock	Performance Stock Options (Right to Buy)	$84.61	2030-08-15	23,881	23,881	Direct
Common Stock	Stock Options (Right to Buy)	$84.61	2030-08-15	29,391	29,391	Direct
Common Stock	Stock Options (Right to Buy)	$52.83	2030-11-01	38,252	38,252	Direct
Common Stock	Performance Restricted Stock Units	$0.00		9,423	9,423	Direct
Common Stock	Performance Stock Options (Right to Buy)	$68.54	2031-02-01	25,945	25,945	Direct
Common Stock	Stock Options (Right to Buy)	$68.54	2031-02-01	51,890	51,890	Direct
Common Stock	Performance Restricted Stock Units	$0.00		51,261	51,261	Direct
Common Stock	Restricted Stock Units	$0.00		25,630	25,630	Direct
Common Stock	Stock Options (Right to Buy)	$74.91	2034-08-15	69,061	69,061	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-08-08	84,308	84,308	Direct
2026-08-07	109,536	109,536	Direct
2027-08-05	115,724	115,724	Direct
2028-08-06	25,944	25,944	Direct
	6,984	6,984	Direct
2029-08-15	21,704	21,704	Direct
2029-08-15	28,940	28,940	Direct
	8,873	8,873	Direct
2030-08-15	23,881	23,881	Direct
2030-08-15	29,391	29,391	Direct
2030-11-01	38,252	38,252	Direct
	9,423	9,423	Direct
2031-02-01	25,945	25,945	Direct
2031-02-01	51,890	51,890	Direct
	51,261	51,261	Direct
	25,630	25,630	Direct
2034-08-15	69,061	69,061	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.67 to $77.66 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.69 to $78.08 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Fully exercisable.
Options to purchase 6,484 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 6,488 shares vest on each of 8/6/2024 and 8/6/2025.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.
Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.
Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.